182 related articles for article (PubMed ID: 26563365)
1. The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.
Cui YY; Yan L; Zhou J; Zhao S; Zheng YB; Sun BH; Lv HT; Rong FN; Chang XT
Tumour Biol; 2016 Apr; 37(4):5375-83. PubMed ID: 26563365
[TBL] [Abstract][Full Text] [Related]
2. PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.
Zheng Y; Zhao G; Xu B; Liu C; Li C; Zhang X; Chang X
Oncotarget; 2016 Sep; 7(38):62159-62176. PubMed ID: 27556695
[TBL] [Abstract][Full Text] [Related]
3. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract][Full Text] [Related]
4. Expression of peptidylarginine deiminase type 4 in ovarian tumors.
Wang L; Chang X; Yuan G; Zhao Y; Wang P
Int J Biol Sci; 2010 Aug; 6(5):454-64. PubMed ID: 20827398
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-enhanced peptidylarginine deiminase type IV gene (PADI4) expression in MCF-7 cells is mediated by estrogen receptor-alpha-promoted transfactors activator protein-1, nuclear factor-Y, and Sp1.
Dong S; Zhang Z; Takahara H
Mol Endocrinol; 2007 Jul; 21(7):1617-29. PubMed ID: 17456793
[TBL] [Abstract][Full Text] [Related]
7. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
[TBL] [Abstract][Full Text] [Related]
8. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
Li L; Duan Z; Yu J; Dang HX
Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
[TBL] [Abstract][Full Text] [Related]
9. Increased PADI4 expression in blood and tissues of patients with malignant tumors.
Chang X; Han J; Pang L; Zhao Y; Yang Y; Shen Z
BMC Cancer; 2009 Jan; 9():40. PubMed ID: 19183436
[TBL] [Abstract][Full Text] [Related]
10. Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.
Xu Y; Ma YH; Pang YX; Zhao Z; Lu JJ; Mao HL; Liu PS
Tumour Biol; 2017 May; 39(5):1010428317701627. PubMed ID: 28475014
[TBL] [Abstract][Full Text] [Related]
11. Role of peptidylarginine deiminase type 4 in gastric cancer.
Xin J; Song X
Exp Ther Med; 2016 Nov; 12(5):3155-3160. PubMed ID: 27882131
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
Zou W; Ma X; Hua W; Chen B; Cai G
Oncol Rep; 2015 Dec; 34(6):3256-63. PubMed ID: 26503358
[TBL] [Abstract][Full Text] [Related]
13. High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer.
Lu J; Wang SL; Wang YC; Wu YN; Yu X; Zhao WZ; Wang JH
Oncotarget; 2017 Jun; 8(25):41189-41201. PubMed ID: 28476025
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
[TBL] [Abstract][Full Text] [Related]
15. HOTAIR Interacting with MAPK1 Regulates Ovarian Cancer skov3 Cell Proliferation, Migration, and Invasion.
Yiwei T; Hua H; Hui G; Mao M; Xiang L
Med Sci Monit; 2015 Jun; 21():1856-63. PubMed ID: 26117268
[TBL] [Abstract][Full Text] [Related]
16. PADI4 Epigenetically Suppresses p21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients.
Fan L; Zong M; Gong R; He D; Li N; Sun LS; Ye Q; Yu S
Int J Biol Sci; 2017; 13(3):358-366. PubMed ID: 28367100
[TBL] [Abstract][Full Text] [Related]
17. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells.
Liu GY; Liao YF; Chang WH; Liu CC; Hsieh MC; Hsu PC; Tsay GJ; Hung HC
Apoptosis; 2006 Feb; 11(2):183-96. PubMed ID: 16502257
[TBL] [Abstract][Full Text] [Related]
19. Role of citrullination modification catalyzed by peptidylarginine deiminase 4 in gene transcriptional regulation.
Zhai Q; Wang L; Zhao P; Li T
Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):567-572. PubMed ID: 28472221
[TBL] [Abstract][Full Text] [Related]
20. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]